retatrutide clinical trial information UK: 2026 & Approval Guide – Trim retatrutide weight loss retatrutide clinical

It works by blocking a protein called PCSK9 and may lead to mild weight loss in some people

Patients who are generally metabolically healthy but require intervention for obesity or overweight

This was accompanied by upregulation of FABP4 and HSL , alongside reduced receptor for advanced glycation end products ( RAGE ) expression, suggesting enhanced lipid turnover and improved adipocyte function

The search included terms such as small molecule GLP-1 receptor agonists, oral GLP-1 receptor agonists, Danuglipron, Orforglipron, and Aleniglipron. Additionally, information on ongoing clinical trials involving small molecule GLP-1 receptor agonists was retrieved from the ClinicalTrials.gov database using the same keywords

11 John Cronin, MD, senior vice president of clinical development at Apnimed, underscores the need for diverse treatment options